Irene Ma (@im_pocus) 's Twitter Profile
Irene Ma

@im_pocus

Professor of Medicine; Internal Medicine;#IMPOCUS; MD, MSc (Epi); PhD (MedEd), RDMS, RDCS, FRCPC, FACP, FAIUM 🏳️‍🌈 🇨🇦 @impocus.bsky.social

ID: 1370752795

calendar_today21-04-2013 22:51:23

3,3K Tweet

2,2K Followers

1,1K Following

Dr. Purvi Parwani (@purviparwani) 's Twitter Profile Photo

Graphic representation of #Echofirst parameters 4assessment of #RV pressure overload from #PE guidelines 1. 🔼RV size 2.Dilated RV 3. Flat IVS 4. Dilated IVC 5. 60/60 sign Pulmo. ET <60ms PASP<60 mmHg 6. RV thrombus 7. TAPSE <16 8. S' velocity <9.5cm/s #ESCCongress

Graphic representation of #Echofirst parameters 4assessment of #RV pressure overload from #PE guidelines 
1. 🔼RV size 
2.Dilated RV 
3. Flat IVS 
4. Dilated IVC
5. 60/60 sign Pulmo. ET &lt;60ms  PASP&lt;60 mmHg 
6. RV thrombus
7. TAPSE &lt;16 
8. S' velocity &lt;9.5cm/s

#ESCCongress
NEJM (@nejm) 's Twitter Profile Photo

Presented at #ESCardio: Among patients with transthyretin amyloidosis with cardiomyopathy, the risk of death from any cause and recurrent cardiovascular events was lower with vutrisiran treatment than with placebo. Full HELIOS-B trial results: nej.md/3X5nl5Q

Presented at #ESCardio: 

Among patients with transthyretin amyloidosis with cardiomyopathy, the risk of death from any cause and recurrent cardiovascular events was lower with vutrisiran treatment than with placebo. Full HELIOS-B trial results: nej.md/3X5nl5Q
NEJM (@nejm) 's Twitter Profile Photo

RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. nej.md/477rpaC #ESCardio

RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. nej.md/477rpaC 

#ESCardio
David H. Wiener, MD (@davidwienermd) 's Twitter Profile Photo

"Words matter:" an 8 society consensus document on nomenclature for cardiac #POCUS. Now we all speak the same language. Led by American Society of Echocardiography Recommendations for Cardiac Point-of-Care Ultrasound Nomenclature - Journal of the American Society of Echocardiography onlinejase.com/article/S0894-…

American Society of Echocardiography (@ase360) 's Twitter Profile Photo

🫀ANOTHER NEW GUIDELINE🫀 We have just released "Recommendations for Cardiac Point-of-Care Ultrasound Nomenclature." Read it here: bit.ly/3MBN9BG #ASEGuidelines #POCUS #CardioX

🫀ANOTHER NEW GUIDELINE🫀
We have just released "Recommendations for Cardiac Point-of-Care Ultrasound Nomenclature." Read it here: bit.ly/3MBN9BG

#ASEGuidelines #POCUS #CardioX
Alberta Sono (@ualberta_sono) 's Twitter Profile Photo

Looking for more detail on Doppler in #POCUS? Principles of Doppler Ultrasonography and Basic Applications for the Clinician - Medical Clinics medical.theclinics.com/article/S0025-… @Buchanan_MD alberto.goffi UAlberta Crit Care UAlberta Med & Dent Irene Ma

Cirrhosis Care Alberta (@cirrhosiscareab) 's Twitter Profile Photo

🩺 Clinicians: CirrhosisCare.ca provides comprehensive guidance for working up the etiology of cirrhosis, including initial lab investigations for conditions like PBC, PSC, and more. A must-have resource for accurate diagnosis and management. cirrhosiscare.ca/cirrhosis-prov…

🩺 Clinicians: CirrhosisCare.ca provides comprehensive guidance for working up the etiology of cirrhosis, including initial lab investigations for conditions like PBC, PSC, and more. A must-have resource for accurate diagnosis and management.

cirrhosiscare.ca/cirrhosis-prov…
Luigi Vetrugno, MD, (@luigivetrugnomd) 's Twitter Profile Photo

Looking with interest at this French study results in ICM for my pleasure ;) 1) JV was the most representative compared with femoral and subclavian vein 2) CRBSI per 1000 CVC days 0.7 for JV and FV and 0.6 for SV 3) In other words, NO DIFFERENCE (p 0.248)

Looking with interest at this French study results in ICM for my pleasure ;)

1) JV was the most representative compared with femoral and subclavian vein  
2) CRBSI per 1000 CVC days 0.7 for JV and FV and 0.6 for SV
3) In other words, NO DIFFERENCE (p 0.248)
Michael Fralick (@fralickmike) 's Twitter Profile Photo

Need a power/sample size calculation for a study or upcoming grant? Led by Emil Hodzic-Santor, we built a simple, free, and pain-free (!) shiny app. feedback welcome plz share with interested parties. check it out: powercalc.ca 🦾🤓 Michelle Sholzberg Kieran Campbell Lianne Jeffs

Need a power/sample size calculation for a study or upcoming grant? Led by <a href="/emil_hs/">Emil Hodzic-Santor</a>,  we built a simple, free, and pain-free (!) shiny app. feedback welcome plz share with interested parties. check it out: powercalc.ca 🦾🤓

<a href="/sholzberg/">Michelle Sholzberg</a> <a href="/kieranrcampbell/">Kieran Campbell</a> <a href="/JeffsLianne/">Lianne Jeffs</a>
Mass General Brigham Professional Development (@massgenbrighcpd) 's Twitter Profile Photo

🚨 Join top experts for the 2025 Vasculitis & Polymyalgia Rheumatica Update! Join us on March 28-29, 2025 to discuss new treatments, diagnostic tools & patient outcomes. #RheumatologyCME #Vasculitis Register Today! cpdlearn.massgeneralbrigham.org/course/2025-up…

🚨 Join top experts for the 2025 Vasculitis &amp; Polymyalgia Rheumatica Update! Join us on March 28-29, 2025 to discuss new treatments, diagnostic tools &amp; patient outcomes. #RheumatologyCME #Vasculitis
Register Today! cpdlearn.massgeneralbrigham.org/course/2025-up…
Irene Ma (@im_pocus) 's Twitter Profile Photo

Our #IMPOCUS learners got treated to visiting professor Dr Gerard Salame’s phenomenal talk on Cardiac Optimization today. Thank you!!! Sorry I was out of commission. Maybe we’ll just have to have you come back :)

Our #IMPOCUS learners got treated to visiting professor Dr Gerard Salame’s phenomenal talk on Cardiac
Optimization today. Thank you!!!  Sorry I was out of commission.  Maybe we’ll just have to have you come back :)
Alexander Mladenow MD (@alex1708ander) 's Twitter Profile Photo

#echofirst #CardioTwitter Middle aged male with MR and evidence of pulmonary hypertension. 🔻 end-systolic D-sign = RV-pressure overload 🔻 mid-systolic notch in RVOT PW Doppler signal 🔻 shortened pulmonary acceleration time (PAT) < 100 ms onlinejase.com/article/S0894-…

Mary Brindle (@maryebrindle) 's Twitter Profile Photo

Implementation Scientists and Ariadne Labs Harvard T.H. Chan School of Public Health This resource put together by Dr.Clara Park, MD, FACS and colleagues Harvard Catalyst is outstanding. 🔥 1. Theories, Models, Frameworks 2. Research Design 3. Implementation Strategies 4. Outcomes catalyst.harvard.edu/dissemination-…

Joel M. Topf, MD FACP (@kidney_boy) 's Twitter Profile Photo

Someone actually did an RCT of the DDAVP Clamp vs rescue use of DDAVP! Seems underpowered so the lack of statistical significance for the primary outcome of overcorrection is a bit suss but faster correction at 48 hours for reactive. nature.com/articles/s4159…

Gigi Liu (@g2disrupt) 's Twitter Profile Photo

W/ @jerrysalame79's collaboration & Irene Ma's leadership, "Basic Cardiac Point-of-Care Ultrasound and Its Clinical Applications" is out! It emphasizes implications of clinical interpretation and applications d/t probe manipulation issues and limitations of various cardiac